|
PXL/HO/Cir-080/2026-27 Date: 16.10.2026
Hyderabad
Chintan Shivir
Industry Interaction on Pharmaceutical Sector – 30 October 2026, Indore
Greetings from PHARMEXCIL.
We are pleased to inform you that the Pharmaceutical Export Promotion Council of India (PHARMEXCIL), functioning under the aegis of the Ministry of Commerce and Industry, Government of India, is organising an Industry Interaction on Pharmaceutical Exports as part of the Chintan Shivir on the Pharmaceutical Industry, scheduled to be held on 30 October 2026 in Indore.
The programme is being organised with the support of the Ministry of Commerce and Industry, Government of India, and will serve as a distinguished platform for constructive deliberations and strategic engagement among senior government officials, regulatory authorities, industry leaders, policy experts, and Chief Executive Officers (CEOs) of leading pharmaceutical companies.
The interaction aims to facilitate constructive dialogue between pharmaceutical exporters and policymakers on key issues concerning market access, regulatory harmonisation, trade barriers, Free Trade Agreements (FTAs), and export promotion measures. It will also focus on identifying policy interventions and strategic opportunities to address industry challenges, enhance the global competitiveness of Indian pharmaceutical companies, and accelerate India’s pharmaceutical export growth.
In this regard, all member companies of PHARMEXCIL are cordially invited to participate in this significant programme and contribute to the deliberations.
Participation is free of charge; however, prior registration is mandatory due to limited seating capacity.
Registration Link:
CHINTAN SHIVIR – Indore, 30 October 2026
Date: 30 October 2026
Timing: 3.00 PM onwards
Event Venue: Brilliant Convention Centre (BCC), Indore, Near Life Care Hospital, Scheme Number 78, Part II, Scheme 78, Vijay Nagar, Indore, Madhya Pradesh 452010
Hall: Imperial Hall.
Event Program:
|
Time
|
Tentative Sessions
|
|
03:00 PM - 03:45 PM
|
Inaugural
|
|
03:50 PM - 4:30 PM
|
Session 1: Presentation by DGFT
Enhancing Global Market Access for Indian Pharmaceuticals through Trade Agreements and Export Facilitation (EPM)
|
|
04:35PM - 05:10 PM
|
Session 2: Presentation by FDA /CDSCO
Global Regulatory Harmonisation to Strengthen Pharmaceutical Exports and Reinforce India’s Position as the “Pharmacy of the World”
|
|
5.10 PM – 5.30 PM
|
Tea Break
|
|
5.30 PM – 6.10 PM
|
Session 3: Presentation by CBN, Gwalior
Controlled Substances in Pharmaceutical Exports: Regulatory Compliance, Licensing and Export Facilitation
|
|
06:20 PM - 07:00PM
|
Session 4: Panel Comprising of Pharmexcil & Key Pharma Associations
Industry Interaction on Key Challenges, Policy Priorities and Strategic Interventions for Strengthening the Indian Pharmaceutical Exports
|
|
7.00 PM onwards
|
Dinner
|
We request members to kindly register at the earliest.
We look forward to your active participation and engagement in the discussions. For any queries you may contact via rodelhi@pharmexcil.com
With warm regards,
Raja Bhanu
Director General
|
